These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34050681)

  • 21. Enamel matrix proteins in the regenerative therapy of deep intrabony defects.
    Tonetti MS; Lang NP; Cortellini P; Suvan JE; Adriaens P; Dubravec D; Fonzar A; Fourmousis I; Mayfield L; Rossi R; Silvestri M; Tiedemann C; Topoll H; Vangsted T; Wallkamm B
    J Clin Periodontol; 2002 Apr; 29(4):317-25. PubMed ID: 11966929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medium- and long-term clinical benefits of periodontal regenerative/reconstructive procedures in intrabony defects: Systematic review and network meta-analysis of randomized controlled clinical studies.
    Stavropoulos A; Bertl K; Spineli LM; Sculean A; Cortellini P; Tonetti M
    J Clin Periodontol; 2021 Mar; 48(3):410-430. PubMed ID: 33289191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term clinical outcomes of periodontal regeneration with enamel matrix derivative: A retrospective cohort study with a mean follow-up of 10 years.
    De Ry SP; Roccuzzo A; Lang NP; Sculean A; Salvi GE
    J Periodontol; 2022 Apr; 93(4):548-559. PubMed ID: 34258767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of enamel matrix derivative alone versus in combination with bone grafts to treat patients with periodontal intrabony defects: a meta-analysis.
    Li W; Xiao L; Hu J
    J Am Dent Assoc; 2012 Sep; 143(9):e46-56. PubMed ID: 22942155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of platelet-rich fibrin vs. enamel matrix derivative in the treatment of periodontal intrabony defects: a clinical and cone beam computed tomography study.
    Gupta SJ; Jhingran R; Gupta V; Bains VK; Madan R; Rizvi I
    J Int Acad Periodontol; 2014 Jul; 16(3):86-96. PubMed ID: 25654961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supracrestal soft tissue preservation with enamel matrix proteins in treatment of deep intrabony defects.
    Trombelli L; Bottega S; Zucchelli G
    J Clin Periodontol; 2002 May; 29(5):433-9. PubMed ID: 12060426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Periodontal regeneration with or without limited orthodontics for the treatment of 2- or 3-wall infrabony defects.
    Ogihara S; Wang HL
    J Periodontol; 2010 Dec; 81(12):1734-42. PubMed ID: 20629545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multi-centre randomized controlled clinical trial on the treatment of intra-bony defects with enamel matrix derivatives/synthetic bone graft or enamel matrix derivatives alone: results after 12 months.
    Meyle J; Hoffmann T; Topoll H; Heinz B; Al-Machot E; Jervøe-Storm PM; Meiss C; Eickholz P; Jepsen S
    J Clin Periodontol; 2011 Jul; 38(7):652-60. PubMed ID: 21564156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term follow-up and tomographic assessment of an intrabony defect treated with enamel matrix derivative.
    Bhatavadekar NB; Paquette DW
    J Periodontol; 2008 Sep; 79(9):1802-8. PubMed ID: 18771385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans.
    Scheyer ET; Velasquez-Plata D; Brunsvold MA; Lasho DJ; Mellonig JT
    J Periodontol; 2002 Apr; 73(4):423-32. PubMed ID: 11990444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. A Cochrane systematic review.
    Esposito M; Grusovin MG; Papanikolaou N; Coulthard P; Worthington HV
    Eur J Oral Implantol; 2009; 2(4):247-66. PubMed ID: 20467602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and histologic evaluation of an enamel matrix derivative combined with a biphasic calcium phosphate for the treatment of human intrabony periodontal defects.
    Sculean A; Windisch P; Szendröi-Kiss D; Horváth A; Rosta P; Becker J; Gera I; Schwarz F
    J Periodontol; 2008 Oct; 79(10):1991-9. PubMed ID: 18834256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of clinical, radiographic, and histometric measurements following treatment with guided tissue regeneration or enamel matrix proteins in human periodontal defects.
    Windisch P; Sculean A; Klein F; Tóth V; Gera I; Reich E; Eickholz P
    J Periodontol; 2002 Apr; 73(4):409-17. PubMed ID: 11990442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of intrabony periodontal defects with enamel matrix derivative in private practice: a long-term retrospective study.
    Saito A; Nanbu Y; Nagahata T; Yamada S
    Bull Tokyo Dent Coll; 2008 May; 49(2):89-96. PubMed ID: 18776720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of surgical flap design (minimally invasive flap vs. extended flap with papilla preservation) on the healing of intrabony defects treated with an enamel matrix derivative: a 12-month two-center randomized controlled clinical trial.
    Windisch P; Iorio-Siciliano V; Palkovics D; Ramaglia L; Blasi A; Sculean A
    Clin Oral Investig; 2022 Feb; 26(2):1811-1821. PubMed ID: 34491446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans.
    Velasquez-Plata D; Scheyer ET; Mellonig JT
    J Periodontol; 2002 Apr; 73(4):433-40. PubMed ID: 11990445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Periodontal regeneration - intrabony defects: a consensus report from the AAP Regeneration Workshop.
    Reynolds MA; Kao RT; Camargo PM; Caton JG; Clem DS; Fiorellini JP; Geisinger ML; Mills MP; Nares S; Nevins ML
    J Periodontol; 2015 Feb; 86(2 Suppl):S105-7. PubMed ID: 25315019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of postsurgical administration of a selective cyclo-oxygenase-2 inhibitor on the healing of intrabony defects following treatment with enamel matrix proteins.
    Sculean A; Berakdar M; Donos N; Auschill TM; Arweiler NB
    Clin Oral Investig; 2003 Jun; 7(2):108-12. PubMed ID: 12720115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical, radiographic, and patient-centered outcomes after use of enamel matrix proteins for the treatment of intrabony defects in patients with aggressive periodontitis: A 12-month multicenter clinical trial.
    Fileto Mazzonetto AL; Casarin RCV; Santamaria MP; Andere NMRB; Araújo CF; Videira Clima da Silva R; Purisaca JEV; Sallum EA; Sallum AW
    J Periodontol; 2021 Jul; 92(7):995-1006. PubMed ID: 33107596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Entire Papilla Preservation Technique with Enamel Matrix Proteins and Allogenic Bone Substitute for the Treatment of Isolated Intrabony Defects: A Prospective Case Series.
    Górski B; Kowalski J; Wyrębek B
    Int J Periodontics Restorative Dent; 2023; 43(3):387-397. PubMed ID: 37141077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.